Phio Pharmaceuticals holds annual shareholder meeting via webcast
Bitget2026/09/28 20:02- Phio Pharmaceuticals held its annual shareholder meeting on Sept. 28, 2026.
- Shareholders authorized an amendment to the 2020 long-term incentive plan, lifting the share reserve by 1,500,000 to 2,452,017.
- The authorization took effect upon shareholder approval; the filing does not confirm any awards have been issued under the expanded pool.
- Grant Thornton was ratified as independent registered public accounting firm for the year ending Dec. 31, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Besent “Extinguishes Fire”: Rising US Treasury yields are a global phenomenon, dismisses concerns over AI bubble
U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.
Bitcoin Crash Warning Goes Viral as X Post Flags Benner Cycle
Crypto prices
More
